Business Type Exporter, Manufacturer, Supplier Payment Mode Online Payments (NEFT/RTGS/IMPS), Cheque/DD Related Products Explore Related Categories More Products From This Seller Seller Details GST - 27AADCO6928M1ZV Trusted Seller Gami Industrial Park, A2,Gala N21, 3rd Floor, C, Park, 39A, TTC Ind Area, MIDC, Pawne, Navi Mumbai, Maharashtra, 400705, India Compare With Similar Products Price Or Price Range 700 INR (Approx.) 700.0 INR (Approx.) 305 INR (Approx.) Minimum Order Quantity 10 Vial/Vials 10 Vial/Vials 200 Dosage Form Lyophilized Powder for Injection Injection Liquid Salt Composition BPC 157 BPC 157 5mg Cisplatin Indication Tissue regeneration, injury recovery, muscle and tendon healing Muscle tears, ligament injuries, stomach ulcers, inflammation Cancer treatment Life Span 24 months from date of manufacture 24 months Pacakaging (Quantity Per Box) 1 Vial / Box 5 vials per box Drug Type Other, Peptide Therapeutic Other, Peptide Ingredients BPC 157 (Body Protective Compound-157) BPC 157 peptide 5mg/vial Other Function Other, Musculoskeletal Healing, Tissue & Tendon Repair Other, Promotes healing and regeneration Recommended For Adults Tissue repair, gut healing, muscle recovery, joint protection Dosage As prescribed by healthcare professional, commonly 2mg per vial As directed by healthcare professional Dosage Guidelines For subcutaneous or intramuscular use only, as directed by physician Inject subcutaneously or intramuscularly as prescribed Suitable For Other, Men, Women, Aged Person Adults Storage Instructions Store in a cool and dry place, protect from light Store in a cool, dry place at 2C-8C, keep away from direct sunlight Stoer in a cold and dry place Supply Ability 1000 Per Month 1000 Per Month 1000 Per Week People Also Viewed
Slightly hygroscopic (delinquesent) in moist air (Windholz, 1983)
Additionally, analogues containing the quinolinium scaffold lacked inhibitory activity against enzymes in the NAD + salvage pathway that bind nicotinamide-containing substrate, including NAMPT[27, 32] and the NAD + -dependent SIRT1 enzyme, which deacetylates NAD + to produce NA, a product inhibitor of SIRT1.[33] These results suggest that quinolinium-based NNMT inhibitors achieve selectivity by specifically interacting with the NA-binding pocket of NNMT,[17] unlike several known non-selective methyltransferase inhibitors that interact with the SAM-binding pocket, which is highly conserved among SAM-dependent methyltransferases.[34, 35] Membrane-permeable NNMT inhibitors reduced intracellular 1-MNA levels in a concentration-dependent manner and at pharmacologically relevant concentrations that did not impact cell viability, suggesting these small molecules interact directly with NNMT in cells
It therefore cannot validate any product in this comparison
10.1101/lm.023267.111 208
Andrew Coniglio, Satyan Sreenath, Kibwei McKinney, Gita Madan, Parth Shah, and Stan McClurg) for their inputs
